CXCL9: evidence and contradictions for its role in tumor progression.
about
Prospects for combined use of oncolytic viruses and CAR T-cells.Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages.Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.A fine-needle aspiration-based protein signature discriminates benign from malignant breast lesions
P2860
CXCL9: evidence and contradictions for its role in tumor progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CXCL9: evidence and contradictions for its role in tumor progression.
@en
CXCL9: evidence and contradictions for its role in tumor progression.
@nl
type
label
CXCL9: evidence and contradictions for its role in tumor progression.
@en
CXCL9: evidence and contradictions for its role in tumor progression.
@nl
prefLabel
CXCL9: evidence and contradictions for its role in tumor progression.
@en
CXCL9: evidence and contradictions for its role in tumor progression.
@nl
P2093
P2860
P356
P1433
P1476
CXCL9: evidence and contradictions for its role in tumor progression.
@en
P2093
Jingmei Liu
Qiang Ding
Shuping Ding
P2860
P304
P356
10.1002/CAM4.934
P407
P5008
P577
2016-10-10T00:00:00Z
2016-11-01T00:00:00Z